Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-12-19

FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for escitalopram oxalate from Amneal Pharmaceuticals LLC under ANDA202227, enabling continued commercialization of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram Oxalate (escitalopram oxalate)

Snippet

SUPPL AP for ESCITALOPRAM OXALATE (ESCITALOPRAM)